Drug News
- Written by: Norris Garman
- Category: Drug News
- Hits: 1905
In the hours since news broke that President Donald Trump struck a tentative deal with Sen. Cory Gardner (R-CO) over future legislation protecting states that have legalized marijuana from federal intervention, there’s been a...
- Written by: Norris Garman
- Category: Drug News
- Hits: 901
Massachusetts voters approved recreational marijuana in 2016, and the narcotic has been available medicinally since 2012—twin realities that have sparked a real estate side effect, so to speak: Neighbors complaining about
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 978
- Written by: Norris Garman
- Category: Drug News
- Hits: 1026
A new poll suggests that opioid abuse in New York is only getting worse. A recent Siena College poll shows 54 percent of New Yorkers say they have been personally touched
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 1032
It's been a bad year so far for Cronos Group (NASDAQ:CRON), with the marijuana grower's share price dropping 14%. But 2018 has been downright horrible for Aphria (NASDAQOTH:APHQF). The stock is
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 923
- Written by: Norris Garman
- Category: Drug News
- Hits: 957
A recent nationwide law enforcement operation has targeted the illegal online market in opioids and cocaine on what's become known as the “dark web,” resulting in eight arrests as well as
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 861
Although marijuana still is a Schedule I narcotic, the Food and Drug Administration (FDA) generally limits its concerns to safety and efficacy. Epidiolex hit both marks during clinical trials underpinning its
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 955
Given the growing problem of opioid addictions and overdose deaths in South Carolina, the state's Department of Education has new expectations of health educators. For example, children in kindergarten should know
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 936
- Written by: Norris Garman
- Category: Drug News
- Hits: 973
None of the largest Canadian marijuana stocks have positive year-to-date returns. Aphria's (NASDAQOTH:APHQF) share price has plunged nearly 40% this year. Theoretically, 2018 should have been a great year for many
...
- Written by: Norris Garman
- Category: Drug News
- Hits: 1095
No one really knows how many people are addicted to opioid use. But almost every organization that deals with the pain-killing drugs agrees that it's a growing problem in the U.S..
...